Atypical femur fractures: Refining the clinical picture

Journal of Bone and Mineral Research

Volumn 27, Issue 5, 2012, Pages 975-976

  Abrahamsen, Bo ^a,b  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; GLUCOCORTICOID;

ATYPICAL FEMUR FRACTURE; BIOMECHANICS; BONE PAIN; BONE RADIOGRAPHY; BONE TURNOVER; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CORTICAL BONE; DEMOGRAPHY; DIAPHYSIS; DISEASE CONTROL; DISEASE REGISTRY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMUR FRACTURE; FEMUR SHAFT; FEMUR SHAFT FRACTURE; FEMUR SUBTROCHANTERIC FRACTURE; FRAGILITY FRACTURE; GROUPS BY AGE; HIP FRACTURE; HUMAN; LONG TERM CARE; NOTE; PATHOPHYSIOLOGY; PRESCRIPTION; RISK FACTOR; SWEDEN; TREATMENT OUTCOME;

FEMALE; FEMORAL FRACTURES; HUMANS; MALE;

EID: 84859900780     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.1610     Document Type: Note

References (8)

1. Park-Wyllie LY, Mamdani MM, Juurlink DN, Hawker GA, Gunraj N, Austin PC, Whealan DB, Weiler PJ, Laupacis A., Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women. JAMA. 2011; 305: 783-9.
2. Abrahamsen B, Eiken P, Eastell R., Cumulative alendronate dose and the long-term absolute risk of subtrochanteric and diaphyseal femur fractures: a register-based national cohort analysis. J Clin Endocrinol Metab. 2010; 95: 5258-65.
3. Feldstein AC, Black D, Perrin N, Rosales AG, Friess D, Boardman D, Dell R, Santora A, Chandler JM, Rix MM, Orwoll E., Incidence and demography of femur fractures with and without atypical features. J Bone Miner Res. 2012; 27: 977-986.
4. Schilcher J, Michaelsson K, Aspenberg P., Bisphosphonate use and atypical fractures of the femoral shaft. N Engl J Med. 2011; 364: 1728-37.
5. Shane E, Burr D, Ebeling P, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R, Dempster D, Einhorn TA, Genant HK, Geusens P, Klaushofer K, Koval K, Lane JM, McKiernan F, McKinney R, Ng A, Nieves J, O'Keefe R, Papapoulos S, Sen HT, van der Meulen MCH, Weinstein RS, Whyte M., Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2010; 25: 2267-94.
6. Unnanuntana A, Ashfaq K, Ton QV, Kleimeyer JP, Lane JM., The effect of long-term alendronate treatment on cortical thickness of the proximal femur. Clin Orthop Relat Res. 2012; 470: 291-8.
7. Keaveny TM, McClung MR, Wan X, Kopperdahl DL, Mitlak BH, Krohn K., Femoral strength in osteoporotic women treated with teriparatide or alendronate. Bone. 2012; 50: 165-70.
8. Carter DR, Hayes WC., Compact bone fatigue damage: a microscopic examination. Clin Orthop Relat Res. 1977; 127: 265-74.